Neuron loss in the brain starts in childhood, increases exponentially with age and is halted by GM-CSF treatment in Alzheimers disease
Sillau, S.; Coughlan, C.; Ahmed, M. M.; Nair, K.; Araya, P.; Galbraith, M.; Bettcher, B.; Espinosa, J. M.; Chial, H.; Epperson, N.; Boyd, T.; Potter, H.
Show abstract
Aging increases the risk of neurodegeneration, cognitive decline, and Alzheimers disease (AD). Currently no means exist to measure neuronal cell death during life or to prevent it. Here we show that cross-sectional measures of human plasma proteins released from dying/damaged neurons (ubiquitin C-terminal hydrolase-L1/UCH-L1 and neurofilament light/NfL) become exponentially higher from age 2-85; UCH-L1 rises faster in females. Glial fibrillary acidic protein (GFAP) concentrations, indicating astrogliosis/inflammation, increase exponentially after age 40. Treatment with human granulocyte-macrophage colony-stimulating factor (GM-CSF/sargramostim) halted neuronal cell death, as evidenced by reduced plasma UCH-L1 concentrations, in AD participants to levels equivalent to those of five-year-old healthy controls. The ability of GM-CSF treatment to reduce neuronal apoptosis was confirmed in a rat model of AD. These findings suggest that the exponential increase in neurodegeneration with age, accelerated by neuroinflammation, may underlie the contribution of aging to cognitive decline and AD and can be halted by GM-CSF/sargramostim treatment.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain 96%
- Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels 95%
- Deciphering cellular transcriptional alterations in Alzheimer's disease brains 95%
Similar papers in this journal
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients 96%
- Early Syndecan-4 Upregulation Predicts Cognitive and Pathological Trajectories in Alzheimer Disease 96%
- Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults 96%
Similar papers in this journal
- Microglial MHC-I induction with aging and Alzheimer's is conserved in mouse models and humans 96%
- A Compound Enhancing Lysosomal Function Reduces Tau Pathology, Microglial Reactivity and Rescues Working Memory in 3xTg AD Mice 95%
- Increased Genetic Protection Against Alzheimer's Disease in Centenarians 95%
Similar papers in this journal
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 97%
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 96%
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 96%